Incentivising Innovation: Are R&D Tax Incentives Worth the Complexity?

Innovation is no longer optional. Whether you’re a regional bank building new digital channels, a manufacturer automating production, or a telecom operator investing in 5G and data platforms, research and development (R&D) and broader innovation spend increasingly sit at the heart of competitive advantage.

The question for boards and CFOs is not just how much to invest in R&D – but where and how to structure those investments to get the best after-tax return.

Around the world, governments are answering that question with a growing array of R&D tax incentives. The OECD’s Corporate Tax Statistics 2025 shows that R&D tax incentives have become a core innovation policy tool, complementing traditional grants and direct funding – and that their generosity has generally increased over the last two decades.

But these incentives come with complexity: detailed eligibility rules, documentation requirements, and evolving international standards to prevent abuse. For Caribbean and wider Latin America and the Caribbean (LAC) businesses, the key question is:

Are R&D tax incentives worth navigating the complexity – and how can you capture the upside without creating new risks?

This article unpacks the global data and offers a practical framework for decision-makers.

1. What exactly are R&D tax incentives?

In the OECD’s framework, R&D tax support comes in two broad forms:

1. Expenditure-based incentives – relief linked to R&D spending, such as:

   • Super-deductions for qualifying R&D costs (e.g. 150% deduction of staff costs)

   • Volume or incremental R&D tax credits

   • Payroll tax reliefs for R&D personnel

2. Income-based incentives – relief linked to income from successful R&D, typically through:

   • IP regimes / “patent box” regimes, where qualifying IP income is taxed at a reduced rate

   • “Dual category” regimes that apply lower rates to both IP income and some non-IP income

Many jurisdictions combine these with direct support (e.g. grants, R&D contracts, government purchases of R&D services)

The OECD Corporate Tax Statistics database now includes three main indicator sets for R&D incentives:

• Government tax relief for business R&D (GTARD) and direct funding, showing total government support as a percentage of GDP.

• Synthetic indicators such as:

  • EATR for R&D

  • Cost of capital for R&D

  • Implied marginal tax subsidy rates (1 − B-Index)

• Income-based incentive indicators, capturing how preferential IP regimes lower the tax on intangible income.

These metrics allow policy-makers – and advisors like Dawgen Global – to compare real tax support across countries, rather than just reading incentive brochures.

2. How generous are R&D tax incentives globally?

2.1 Government support has grown and shifted toward tax relief

The OECD’s GTARD and direct funding data (covering 48 jurisdictions from 2000–2023) show that:

• Many countries now rely heavily on tax-based support rather than grants alone.

• In 2023, 20 OECD jurisdictions provided more than 50% of total government support for business R&D through the tax system, and in six of them (including Australia, Colombia and Ireland) this share reached 75% or more.

• A smaller group still relies only on direct support (e.g. Costa Rica, Estonia, Israel, Latvia, Luxembourg and Switzerland)

This confirms a structural shift: R&D tax incentives are now a central pillar of innovation policy, not a marginal add-on.

2.2 Expenditure-based incentives: cutting the cost of capital

When you incorporate expenditure-based incentives into the effective tax modelling for R&D, the impact is clear:

• In 2024, the average EATR for R&D including expenditure-based incentives across 51 jurisdictions was 14.2% – 7.3 percentage points below the rate under standard tax treatment

• The cost of capital for R&D fell to an average of 0.2%, 2.9 percentage points below the standard tax treatment.

The OECD also finds that tax incentives have reduced the cost of R&D capital dramatically in recent years. Between 2019 and 2024, tax incentives reduced the cost of R&D capital by 92% in 2023 and 93% in 2024 

In plain language: R&D tax incentives can turn a marginal project into a commercial one by significantly lowering the required pre-tax return.

2.3 Implied subsidy rates and the SME angle

The B-Index (and its complement, the implied marginal tax subsidy rate 1 − B) provides another lens. The OECD’s data show:

• Implied marginal R&D tax subsidy rates have generally risen over 2000–2024, with particularly large jumps around the 2008 financial crisis and the COVID-19 shock in 2019–2020.

• Subsidy rates are persistently higher for SMEs than for large firms, and higher for profitable firms than for loss-makers – suggesting policy intent to tilt support towards smaller, dynamic businesses.

• Provisions like refundability (as seen in Austria and Norway) help align subsidy levels for loss-making and profitable firms, while jurisdictions relying only on carry-forward or with no such provisions see much weaker support for loss-making firms.

For Caribbean SMEs, this is a critical insight: well-designed incentive regimes can be particularly powerful for growing firms, not just large multinationals.

2.4 Income-based incentives and IP regimes

On the income side, the OECD notes a strong expansion in income-based R&D tax incentives:

• In 2024, 21 out of 38 OECD countries offered income-based incentives for R&D and innovation, up from only 4 countries in 2000 

• Almost all of these combine income-based incentives with expenditure-based incentives such as R&D tax credits

These incentives typically operate through IP regimes – often described as “patent boxes” – where qualifying IP income is taxed below the standard corporate rate. The Corporate Tax Statistics database records 65 IP regimes in 50 jurisdictions in 2025

Importantly:

• 46 regimes are now classified as “not harmful” under BEPS Action 5, including 26 that were amended to meet the nexus requirement (linking benefits to R&D actually performed in the jurisdiction)

• Reduced tax rates on IP income range from 0% in 18 jurisdictions to around 18.75% at the upper end; a 50% reduction from the normal rate is the most common design

From the investor’s perspective, this is a powerful lever:

• The average EATR on internally generated R&D intangibles in OECD countries has fallen from 23.3% in 2000 to 12.9% in 2024 

• Even without income-based incentives, the EATR dropped from 26.6% to 19.8%, driven by lower statutory rates. Across all 51 countries in the sample, the EATR fell from 26.8% to 19.5% 

• Income-based incentives alone reduce the EATR for internally generated R&D intangibles by an average of 7.2 percentage points – a 37% cut in the effective burden. 

In some countries, the EATR on income-incentive-supported R&D intangibles can even be negative – a sign of extremely generous regimes where the tax system effectively subsidises intangible returns

3. The trade-offs: why R&D incentives can feel “too complicated”

Given these numbers, it might seem obvious that every business should chase every incentive available. In practice, many boards and CFOs hesitate – and with good reason.

3.1 Complexity and administrative burden

R&D tax incentives are often heavily rule-driven:

• Tight definitions of what counts as qualifying R&D

• Detailed tracking of staff time, project costs and IP income streams

• Requirements to maintain documentation for audits, often for many years

For businesses with limited internal tax capability, the cost of compliance – time, systems, advisors – can feel substantial, particularly where incentives are modest or uncertain.

3.2 Uncertainty and disputes

Incentives tend to generate:

• Subjective boundary questions (what is “innovative”? what is routine engineering?)

• Disputes with tax authorities, especially where claims are aggressive or poorly evidenced

• Retroactive risk if regimes are redesigned or scaled back after incentives have been claimed

This is especially sensitive in jurisdictions with evolving administrative practices or less predictable policy-making.

3.3 Interaction with BEPS and IP regimes

Income-based incentives are now constrained by BEPS Action 5:

• IP regimes must comply with the nexus approach, tying tax benefits to R&D undertaken in the jurisdiction providing the relief

• Regimes that fail these tests can be classified as harmful or be forced to close; some have already been abolished or are being amended .

For businesses, this means:

• Substance is non-negotiable – IP holding structures with little real activity are increasingly high-risk.

• Legacy regimes may continue only under grandfathering rules that expire by dates such as 31 December 2025

3.4 Unequal access

Not every jurisdiction in the Caribbean and LAC region offers the same mix of R&D incentives as OECD members. Some rely on:

• Direct support and grants rather than tax incentives

• Sector-specific regimes (e.g. for ICT, BPO, energy)

• General investment incentives that only partially overlap with R&D

Regional groups investing in multiple markets therefore face a patchwork – and must align R&D locations with talent, infrastructure, and customer proximity, not just tax incentives.

4. A practical framework for Caribbean and LAC businesses

The global data show that R&D tax incentives can materially reduce the effective cost of innovation. The challenge is how to capture that value sensibly. Here’s a framework for boards and CFOs.

4.1 Start with your innovation strategy, not the incentive

Begin by clarifying:

• Where do we genuinely need to perform R&D (talent, ecosystem, proximity to operations/customers)?

• What types of innovation matter most – digital, process, product, business model?

• What is our realistic R&D spend over the next 3–5 years?

Then ask: Which jurisdictions that align with our business strategy also offer meaningful, sustainable tax support? Let the commercial and innovation logic lead; use tax incentives to amplify, not dictate, the strategy.

4.2 Map the R&D incentive landscape across your footprint

For each country where you operate or may invest in R&D:

• Identify expenditure-based incentives: super-deductions, credits, payroll reliefs, accelerated depreciation for R&D assets.

• Identify income-based incentives: IP regimes, patent boxes, preferential rates for qualifying intangible income.

• Consider direct support: grants, innovation funds, public–private R&D programmes.

Overlay this with the effective tax metrics:

• EATR for R&D with and without incentives

• Cost of capital for R&D

• Implied subsidy rates for SMEs vs large firms, profit vs loss

This will help prioritise where R&D should be located from an after-tax perspective, subject to your business constraints.

4.3 Build incentives into your business cases – conservatively

When evaluating major R&D or innovation projects:

• Model base-case NPV/IRR without incentives, then show upside from:

  • Expenditure-based incentives (lower initial cash cost, higher after-tax returns)

  • Income-based incentives (reduced tax on future IP income)

• Include sensitivity analysis for:

  • Lower-than-expected qualifying expenditure

  • Delays in approval or changes in regime design

  • Partial or no access for loss-making periods

The board should see incentives as upside, not the sole justification for a project.

4.4 Invest in documentation and governance

Given the risk of challenge, it is essential to:

• Define internal R&D eligibility guidelines, aligned with legislation and OECD definitions.

• Capture project-level documentation: objectives, uncertainties, methodologies, outcomes.

• Track time and costs systematically (especially staff time and subcontractor costs).

• Integrate R&D incentives into your tax governance framework, with clear approval thresholds and sign-offs.

This turns incentives from “a clever tax play” into a well-governed element of your innovation financing model.

4.5 Align IP and substance with BEPS-compliant regimes

If you intend to benefit from income-based incentives through IP regimes:

• Ensure R&D activity, IP ownership and economic risk are meaningfully aligned in the chosen jurisdiction.

• Avoid hollow IP holding structures with little staff, decision-making or infrastructure.

• Monitor regime status (e.g. BEPS Action 5 reviews) to avoid reliance on regimes that may soon be abolished or downgraded.

For Caribbean groups with cross-border R&D and IP, this often requires re-designing existing structures to be both tax-efficient and demonstrably substance-rich.

5. Are R&D incentives “worth it”? Our view

Looking at the OECD data and regional realities, the answer for most medium and large businesses is yes – provided they are approached strategically.

Why they’re worth it:

• They can cut effective tax rates on R&D and intangible income dramatically – often by 7–10 percentage points or more.

• They lower the cost of capital for innovation, making more projects viable and improving competitiveness

• They increasingly target SMEs and high-growth firms, which are central to Caribbean diversification and digitalisation

Why they must be handled with care:

• Complexity and documentation requirements are real and increasing.

• BEPS, IP regime reviews and potential Pillar Two interactions create a moving regulatory target.

• Poorly designed or overly aggressive claims can lead to disputes, clawbacks and reputational risk.

For Caribbean and LAC groups, the optimal path is not to avoid incentives, but to treat them as a strategic, governed pillar of your innovation and tax strategy – supported by specialist advice.

6. How Dawgen Global can help

Dawgen Global works with clients across Jamaica, the wider Caribbean and beyond to turn complex R&D tax rules into practical, value-adding strategies.

Our Tax Services team can support you to:

• Map R&D incentive opportunities across your current and target jurisdictions.

• Build EATR and cost-of-capital models that show how incentives change the economics of your R&D and innovation projects.

• Design and implement R&D documentation frameworks that meet both tax and audit standards.

• Evaluate and optimise IP and R&D locations, balancing incentives with BEPS-compliant substance.

• Support you through claims, reviews and disputes, reducing risk while maximising sustainable benefit.

We bring together OECD-level technical insight, regional experience and a deep understanding of the innovation agenda facing Caribbean businesses.

Next Step!

If your organisation is investing – or planning to invest – in innovation, now is the time to ask whether you are leaving R&D tax value on the table, or taking unnecessary risks in how you claim it.

To explore how R&D tax incentives can be integrated into your innovation and tax strategy, connect with Dawgen Global’s Tax Services Team:

📧 Email: [email protected]
📱 WhatsApp (Global): +1 555 795 9071

At Dawgen Global, we help you make Smarter and More Effective Tax Decisions – including how you finance innovation.

About Dawgen Global